A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges-Reference-Cited by-同舟云学术

A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges

Published:2011-01-19 Issue:2 Volume:10 Page:193-197
ISSN:1389-9600
Container-title:Familial Cancer
language:en
Short-container-title:Familial Cancer

Author:

Daniels Molly S.,Burzawa Jennifer K.,Brandt Amanda C.,Schmeler Kathleen M.,Lu Karen H.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics (clinical),Oncology,Genetics

Link

http://link.springer.com/content/pdf/10.1007/s10689-011-9418-1.pdf

Reference24 articles.

1. Malander S et al (2004) One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. Eur J Cancer 40(3):422–428

2. Pal T et al (2005) BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104(12):2807–2816

3. Risch HA et al (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68(3):700–710

4. Hampel H et al (2006) Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 66(15):7810–7817

5. Hampel H et al (2005) Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352(18):1851–1860

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Intersection of Palliative Care and Genetic Counseling in Cancer Care: A Case Discussion;Journal of Palliative Medicine;2022-01-01

2. Views and experiences of palliative care clinicians in addressing genetics with individuals and families: a qualitative study;Supportive Care in Cancer;2021-09-22

3. Genetic Counseling and Testing;The Hereditary Basis of Childhood Cancer;2021

4. Multidisciplinary interventions in a specialist Drug Development Unit to improve family history documentation and onward referral of patients with advanced cancer to cancer genetics services;European Journal of Cancer;2019-06

5. Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The “Opt-Out” Process;Journal of Oncology;2019-04-02